AlphaStocks
5.3
Consider Buy

Xencor Inc (XNCR)

As of Sep 20, 2026, Xencor Inc (XNCR) scores 5.3/10 on AlphaStocks' five-model composite, #91 of 168 Health Care stocks. At $25, XNCR trades 11% below its model fair value of $28.

Health Care / Biotechnology

S&P SmallCap 600

$24.73

Below average on several measures. Research carefully.

Consider Buy

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#91out of 168 in Health Care

Is Xencor Inc a Good Investment in 2026?

Xencor Inc (XNCR) scores 5.3 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model is the most favorable, rating Xencor Inc as Neutral. However, the Greenblatt Magic Formula model rates it Caution — Earnings yield -14.3% · ROC -32%. Xencor Inc currently trades 11% below its estimated fair value of $28. Xencor Inc ranks #91 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE-14.6Market Cap2B

Estimated Fair Value

$27.6511% below

Trading below estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Neutral

3/9

Buffett

Caution

Business quality & competitive moat

Graham

Neutral

Price vs intrinsic value

Lynch

Neutral

Growth rate vs price (PEG)

Greenblatt

Caution

Earnings yield -14.3% · ROC -32%

Frequently Asked Questions

Is Xencor Inc (XNCR) a good investment?
As of Sep 20, 2026, Xencor Inc (XNCR) scores 5.3/10 on AlphaStocks' five-model composite, #91 of 168 Health Care stocks. At $25, XNCR trades 11% below its model fair value of $28. That score is below average, suggesting caution.
What is Xencor Inc's Piotroski F-Score?
Xencor Inc's Piotroski F-Score status is Neutral. The raw score is 3/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is XNCR overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $28, XNCR appears undervalued. The stock currently trades 11% below its estimated fair value. Trading below estimated fair value.
How does XNCR compare to other Health Care stocks?
Xencor Inc ranks #91 out of 168 stocks in the Health Care sector, placing it in the top 54% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about XNCR?
AlphaStocks evaluates XNCR using five proven investment models. Piotroski: Neutral; Buffett: Caution; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 5.3/10.

Similar Stocks

ABBVINCYHRMY

Compare XNCR with

ABBV vs XNCRINCY vs XNCRHRMY vs XNCR

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer